If you carry a diagnosed condition such as prediabetes or hypertension, we coordinate directly with your primary care provider so your treatment fits your broader care
Canadian patients might access it via online peptide suppliers (with all the caveats that entails) or cross-border if they have a U.S
What if I experience side effects at higher doses
This innovative therapy, delivered under the care of Dr
Burwinkel B, Kreuder J, Schweitzer S, Vorgerd M, Gempel K, Gerbitz KD, Kilimann MW: Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality
Expected Eligibility Criteria Based on clinical trial populations and existing medication precedents, Retatrutide will likely require one of the following